Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice a strange taste, often described as metallic or bitter, shortly after injecting Mounjaro. It is real, it is reported by a noticeable proportion of users, and it has a plausible biological explanation. Mounjaro (tirzepatide) is a prescription-only weight-loss and diabetes medicine that works on two gut-hormone receptors simultaneously — and that same mechanism affects digestion, saliva production and how your brain interprets flavour signals. The taste usually passes quickly and is not a sign that something has gone wrong, though it is worth knowing what to watch for and when to flag it to a clinician.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both GIP and GLP-1 receptors, making it the only dual-agonist weight-loss medicine licensed in the UK. Those receptors are not confined to fat cells or the pancreas, GLP-1 receptors sit in the brainstem and hypothalamus, regions that process sensory signals including taste. When the medicine begins to circulate, it can subtly alter how the brain reads flavour information arriving from the tongue and mouth.
There is also a more mechanical reason. Mounjaro significantly slows gastric emptying, food and stomach acid move through your digestive system more gradually than usual. In some people this produces a faint reflux-like effect, particularly in the first few hours after a dose, which can register as a metallic, sour or medicinal note at the back of the throat. It is not stomach acid in the clinical sense; it is a perceptual shift driven by slower transit.
Saliva composition can shift too. GLP-1 activity influences autonomic nerve signals that govern salivary glands, and a change in saliva pH or enzyme balance can make familiar foods and drinks taste different. Some people specifically notice it with coffee, alcohol or fatty foods, all of which are processed more slowly on tirzepatide anyway. The NHS tirzepatide medicines page lists altered taste as a known side effect.
For most people the sensation peaks in the first one to three hours post-injection and then fades. A smaller group notice a milder background taste for most of that first day. By week four or five of treatment, when the body has adapted to consistent tirzepatide levels, the majority of users report the effect has either disappeared or reduced to something they barely clock.
Dose increases can temporarily bring it back. When you move from 2.5 mg to 5 mg, or higher, the step up in receptor activation is enough to reintroduce sensory effects that had settled. This is normal and mirrors the broader GI pattern, nausea and fullness that eased at a lower dose can return briefly after each titration step before settling again.
One practical habit worth building into your injection routine: in the hour or so after dosing, take a small sip of plain water and notice whether the taste is present. Tracking this (even just a note in your phone) gives you useful information to share at your next clinical review. It takes under a minute and can help your prescriber see how your body is tolerating each dose level. If you want to understand more about why a funny taste in your mouth after a Mounjaro injection occurs, our dedicated page explores the causes and what you can do about it. For more detail on what to expect immediately after dosing, our page on what happens with your Mounjaro pen after injection covers the practical steps from capping through disposal.
The effect tends to correlate loosely with dose, because higher concentrations produce stronger receptor activation and more pronounced gastric slowing. People at 2.5 mg (the starting dose, which exists to settle your system rather than to produce significant weight loss) often report minimal taste disturbance. Those at 10 mg or 15 mg are more likely to notice it, though individual variation is wide.
Injection timing plays a role that is sometimes underestimated. If you inject shortly after a large meal, the gut is already working hard; adding tirzepatide's braking effect on top can intensify both the GI burden and any associated taste sensation. Injecting on a relatively empty stomach (or at least two hours after eating) tends to reduce this. Our page on injecting Mounjaro after a meal goes into the timing evidence in more depth.
Rotating injection sites is also worth maintaining consistently. Absorption rate varies slightly by site (abdomen, thigh, upper arm) and erratic rotation can affect how quickly tirzepatide peaks in your bloodstream, which may influence intensity of early side effects including taste. Injection technique details, from choosing a site to checking the pen, are covered on our Mounjaro injection technique page.
A brief metallic or bitter note that fades within a few hours is benign. The situations worth escalating are different in character. If the taste is accompanied by severe stomach pain that spreads toward the back, that combination (pain plus GI symptoms) is the pattern to act on urgently, because acute pancreatitis is a known but infrequent risk with GLP-1 medicines; the MHRA issued specific guidance on this in early 2026, and any such symptoms warrant same-day medical assessment rather than waiting for a routine review.
A persistent metallic taste lasting several days, or taste changes that worsen rather than ease between doses, should also be flagged. Occasionally a prolonged taste disturbance points to something unrelated to tirzepatide (a dental issue, a nutritional deficiency, a concurrent medicine) and your prescriber can help unpick that. If you notice a skin reaction around the injection site alongside any sensory changes, our page on rashes after Mounjaro injection outlines when those, too, need clinical attention.
You can report any suspected side effect directly to the MHRA through the Yellow Card scheme. For broader questions about your treatment or dose, speaking to our prescribers is the straightforward next step, every review at nume is handled by a GPhC-registered prescriber, not automated software, and that includes aftercare queries seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.